Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Exp Ther Med 20(3):23962400 Lee YS, Jun HS (2014) Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
*Correspondence: Renjie Xiao, [email protected] Deng, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
We found significantly increased mTOR activity in LTR compared to STR (Fig
Older adults (where sarcopenia compounds the effect), people starting with lower muscle mass, anyone eating very little protein, and those doing no resistance training
Even though GLP-1s are currently considered safe for a wide variety of users, substance abuse factors add a unique element that needs to be studied for safety
How soon will I notice the results
